LATEST STATUS as of October 2026: permanent UK puberty-blocker ban in force since January 2025 (review due 2027); PATHWAYS puberty-blocker clinical trial commissioned November 2025 by NHS England/NIHR with King's College London; March 2026 NHS England paused new cross-sex hormone prescriptions for under-18s pending consultation (ran 9 March – 7 June 2026); final policy expected autumn 2026.
LATEST STATUS as of October 2026: permanent UK puberty-blocker ban in force since January 2025 (review due 2027); PATHWAYS puberty-blocker clinical trial commissioned November 2025 by NHS England/NIHR with King's College London; March 2026 NHS England paused new cross-sex hormone prescriptions for under-18s pending consultation (ran 9 March – 7 June 2026); final policy expected autumn 2026. Official parliamentary briefing; used for current-status verification.
